Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection

ClinicalTrials.gov ID: NCT01924793

Public ClinicalTrials.gov record NCT01924793. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This protocol will seek to enroll up to 60 immunocompromised subjects diagnosed with parainfluenza infection. All subjects will have additional PK and Immunogenicity blood samples collected.

Study identification

NCT ID
NCT01924793
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ansun Biopharma, Inc.
Industry
Enrollment
23 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2013 (Type not available)
Primary completion
May 2017 (Actual)
Completion
May 2017 (Actual)
Last update posted
Jul 19, 2017

2013 – 2017

United States locations

U.S. sites
23
U.S. states
18
U.S. cities
21
Facility City State ZIP Site status
City of Hope Duarte California 91010 —
Children's Hospital of Orange County Orange California 92868 —
Stanford University Medical Center Palo Alto California 94305 —
University of Chicago Chicago Illinois 60637 —
Indiana Blood and Marrow Transplantation Indianapolis Indiana 42367 —
University of Kansas Cancer Center Kansas City Kansas 66160 —
John Hopkins University School of Medicine Baltimore Maryland 21287 —
Brigham & Women's Hospital Boston Massachusetts 02115 —
University of Minnesota, School of Medicine Minneapolis Minnesota 55455 —
Washington University School of Medicine St Louis Missouri 63110 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Weill Cornell Medical College/New York Presbyterian Hospital New York New York 10021 —
Weill Cornell Medical College-Peds New York New York 10065 —
Duke University Durham North Carolina 27710 —
The Ohio State University Wexner Medical Center Columbus Ohio 43210 —
University of Oklahoma Oklahoma City Oklahoma 73104 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Medical University of South Carolina Charleston South Carolina 29425 —
St. Jude Children's Research Hospital Memphis Tennessee 38105 —
The University of Texas MD Anderson Cancer Center Houston Texas 77030 —
Seattle Children's Hospital Seattle Washington 98105 —
Fred Hutchinson Cencer Research Center Seattle Washington 98109-1024 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01924793, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2017 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01924793 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →